Learn, apply, discover.

Accurate protein identification and quantification are central to extracting meaningful biological insights from mass spectrometry (MS)-based proteomics.

Our collaborators at NYU have deposited a preprint on bioRxiv describing the use of Tesorai for identifying cancer antigens that could be used for therapeutic targeting.

The Tesorai team has updated the bioRxiv preprint describing the implementation of Tesorai Search, including detailed benchmarking of Tesorai against other leading software across multiple datasets.